Ataraxis AI (Series A)
Funding Details
Awarder
Inbox
Date Award
May 18, 2025
Vertical
Biotech and Health
Funding URL
View Funding Page
Funding Amount
$20,400,000
Company Info
Traction
Ataraxis plans to launch its first commercial test for breast cancer to U.S. oncologists and aims to impact at least half of new cancer cases by 2030.
Founders
Jan Witowski, Krzysztof Geras
Market
Cancer treatment
Location
New York, USA
Coinvestors
AIX Ventures, Thiel Bio, Founders Fund, Floating Point, Bertelsmann, Giant Ventures, Obvious Ventures
Company Description

Ataraxis AI is focused on using AI to accurately predict cancer outcomes and personalize treatment, potentially avoiding unnecessary chemotherapy for patients.

Links
Website
Back to HomeBack to Biotech and Health DealsView Funding Announcement